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Closed-Loop Fluid Resuscitation
Control Via Blood Volume
Estimation
This paper presents a closed-loop control of fluid resuscitation to overcome hypovolemia
based on model-based estimation of relative changes in blood volume (BV). In this
approach, the control system consists of a model-based relative BV (RBV) estimator and
a feedback controller. The former predicts relative changes in the BV response to aug-
mented fluid by analyzing an arterial blood pressure (BP) waveform and the electrocar-
diogram (ECG). Then, the latter determines the amount of fluid to be augmented by
comparing target versus predicted relative changes in BV. In this way, unlike many previ-
ous methods for fluid resuscitation based on controlled variable(s) nonlinearly correlated
with the changes in BV, fluid resuscitation can be guided by a controlled variable linearly
correlated with the changes in BV. This paper reports initial design of the closed-loop
fluid resuscitation system and its in silico evaluation in a wide range of hypovolemic sce-
narios. The results suggest that closed-loop fluid resuscitation guided by a controlled
variable linearly correlated with the changes in BV can be effective in overcoming hypo-
volemia: across 100 randomly produced hypovolemia cases, it resulted in the BV regula-
tion error of 7.98 6 171.6 ml, amounting to 0.18 6 3.04% of the underlying BV. When
guided by pulse pressure (PP), a classical controlled variable nonlinearly correlated
with the changes in BV; the same closed-loop fluid resuscitation system resulted in persis-
tent under-resuscitation with the BV regulation error of 779.1 6 147.4 ml, amounting to
13.9 6 2.65% of the underlying BV. [DOI: 10.1115/1.4033833]
Introduction
Hypovolemia refers to a state of decreased BV, attributable to
many injuries and pathophysiologic conditions such as hemor-
rhage, burns, trauma, and infections (e.g., sepsis) [1–8]. Patients
with hypovolemia require fluid resuscitation to restore their
volume state. The ultimate goal of fluid resuscitation is to restore
venous return, cardiac output (CO), and essentially BP, by opti-
mizing BV. In many hypovolemic scenarios, early and closely
monitored resuscitation is crucial for survival; previous investiga-
tions indicate that delayed and inadequate fluid resuscitation was
shown to be responsible for increased mortality and morbidity
[3,9–11], while over-resuscitation resulted in adverse side effects
such as pulmonary edema [12].
Considering the lack of established therapeutic guidelines for
fluid resuscitation [13–15], clinicians have used a variety of thera-
peutic endpoints of his/her own choice to perform fluid resuscita-
tion. Examples include BP, PP, central venous pressure, urine
output, PP variability (PPV), and so on [14,16–28]. A big problem
associated with today’s manual and heterogeneous treatment pro-
tocols is that it is very challenging for a clinician to deliver con-
sistent quality in fluid resuscitation across these diverse endpoints
and strategies, due to the limited familiarity with all the therapeu-
tic protocols as well as the extreme workload. Therefore, new
technological advances in automated closed-loop control for fluid
resuscitation may largely improve the treatment efficacy while
reducing clinician’s workload. Especially, such a technology may
find meaningful applications in low-resource settings such as
combat/mass casualty care.
Though (perhaps) the first closed-loop control system for fluid
resuscitation was reported in early 1980s [29], it is only very
recently that closed-loop fluid resuscitation started to receive
significant attention, with several closed-loop control and
decision-support systems reported in the literatures [14,16–28,
30–33]. Similarly to manual fluid resuscitation, the goal in many
of these systems is to augment fluid until a physiologic endpoint
(such as BP, CO, tissue oxygenation, urine output, and PPV)
reaches a target set by the clinician. The underlying assumption is
that BV can be optimized (i.e., the sensitivity of BV to additional
fluid augmentation is minimized) by regulating these physiologic
endpoints to a target. However, the success of the above-
mentioned efforts has been modest due to the limited efficacy of
the controlled variables used. Most importantly, the controlled
variables are not linearly correlated with BV, which may poorly
predict fluid responsiveness [22,34–39]. In particular, a few recent
reports indicate that PP, a well-known surrogate measure of stroke
volume (SV), underestimates SV [40–42]. Thus, a major leap in
the closed-loop fluid resuscitation technology must be accompa-
nied by advancement in the monitoring technologies for BV-
responsive endpoints. For this reason, we envision that the capa-
bility for high-fidelity estimation of BV may enable more effec-
tive BV management in hypovolemic patients.
This paper presents a closed-loop control of fluid resuscitation
to overcome hypovolemia based on model-based estimation of
relative changes in BV (called RBV). In this approach, the control
system consists of a model-based RBV estimator and a feedback
controller. The former predicts the RBV response to augmented
fluid by analyzing an arterial BP waveform and the ECG. Then,
the latter determines the amount of fluid to be augmented by com-
paring target versus predicted RBV. In this way, unlike many pre-
vious methods for fluid resuscitation based on controlled
variable(s) nonlinearly correlated with the changes in BV (here-
after called as nonlinear surrogate(s)) [25,43–45], fluid resuscita-
tion can be guided by a controlled variable linearly correlated
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with the changes in BV (hereafter called as linear surrogate). This
paper reports initial design of the closed-loop fluid resuscitation
system and its in silico evaluation in a wide range of hypovolemic
scenarios.
Closed-Loop Fluid Resuscitation
The closed-loop fluid resuscitation system proposed in this pa-
per is made up of a model-based RBV estimator and a closed-loop
controller as well as an infusion pump as an actuator and a BP
monitor and ECG as sensors (Fig. 1). The model-based RBV esti-
mator predicts the relative changes in LV EDV as RBV response
to fluid, by analyzing an arterial BP waveform and the ECG based
on a LV pressure–volume (P–V) loop model [46–51]. The closed-
loop controller compares the discrepancy between target versus
predicted RBV and computes the amount of fluid that must be
augmented to optimize BV. The integration of a RBV estimator
and a closed-loop controller enables fluid resuscitation with a lin-
ear surrogate of BV, which may outperform many previous fluid
resuscitation methods relying on nonlinear surrogates of BV. The
RBV estimator and the closed-loop controller are described in
detail below.
Model-Based BV Estimation. The model-based RBV estima-
tor predicts the RBV response to fluid by analyzing an arterial BP
and the ECG. The estimator is built upon an LV P–V loop model
[46–51] (Fig. 2). The model is governed by the end-systolic and
end-diastolic P–V relationships given by
PSðVðtÞÞ ¼ ESðVðtÞ  V0Þ (1a)
PDðVðtÞÞ ¼ B½eAðVðtÞV0Þ  1 (1b)
where PS (mmHg) and PD (mmHg) are the BP values correspond-
ing to the end-systolic and end-diastolic P–V relationships at an
LV volume VðtÞ (ml), ES (mmHg/ml) is the end-systolic LV ela-
stance, A and B are constants specifying the end-diastolic P–V
relationship, and V0 (ml) is the LV volume corresponding to zero
LV pressure. The so-called maximum LV pressure is then given
by the weighted average of PS and PD
PmaxLV ðtÞ ¼ /ðtÞPSðVðtÞÞ þ ð1 /ðtÞÞPDðVðtÞÞ (2a)




where /ðtÞ is the activation function [46,47] and Tes is the ejection
duration, which may be derived from the analysis of an arterial
BP waveform [52,53]. It is noted that PmaxLV ðtÞ versus VðtÞ
Fig. 1 Closed-loop fluid resuscitation via model-based estimation of relative changes in left-ventricular (LV) end-diastolic
volume (EDV) as linear surrogate of relative changes in BV
Fig. 2 Model-based RBV estimation: (a) LV pressure–volume (P–V) loop and (b)–(d) Estima-
tion of LV P–V loop based on BP and ECG
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constitute the LV P–V loop (the black solid loop in Fig. 2(a)). It
hits the end-systolic P–V relationship at the end systole upon the
aortic valve closure, at which VðtÞ corresponds to end-systolic
volume (ESV) Ves. In addition, it overlaps with the end-diastolic
P–V relationships during the LV filling period, at the end of which
VðtÞ becomes EDV Ved. Considering the triangle constructed by
the ðVðtÞ; PðtÞÞ coordinates ðV0; 0Þ, ðVes; PesÞ, and ðVed; 0Þ, the
following relationships hold at the end-systole:
Pes ¼ ESðVes  V0Þ (3a)
Pes ¼ EAðVed  VesÞ ¼ EASV (3b)
where EA (mmHg/ml) is called the arterial elastance [46,47], and
SV is SV (ml). Under the assumption that end-systolic BP is very
close to mean BP [54–56], Eq. (3b) can be rewritten as follows:
Pm ¼ R  FHR  SV ¼ EASV (3c)
where Pm (mmHg) is mean BP, R (mmHg min/ml) is total periph-
eral resistance (TPR), and FHR (bpm) is heart rate (HR). It is
obvious from Eq. (3c) that EA ¼ R  FHR.
The above governing equations for the LV P–V loop form the
basis for the model-based RBV estimator as described in detail
below. The model-based RBV estimator predicts the trends of
Ved, Ves, and SV values in four steps, by analyzing the measure-
ments of an arterial BP and the ECG (Figs. 2(b)–2(d)). The under-
lying assumption is that the values of A and B in the end-diastolic
P–V relationship in Eq. (1b) are known a priori. Since the estima-
tor predicts Ved, Ves, and SV in the absence of any BV and/or
blood flow measurements, it can only predict scaled (rather than
absolute) BV values. In Step 1, a value is assumed for ES (this is
necessary because only BP but not BV and/or blood flow is avail-
able). This allows the end-systolic P–V relationship to be con-
structed (Fig. 2(b)). In Step 2, Ved  V0 is predicted using Eq. (2)
based on the measurement of diastolic BP (Fig. 2(c))
PmaxLV ðtdÞ ¼ Pd ¼ /ðtdÞPSðVedÞ þ ð1 /ðtdÞÞPDðVedÞ (4)
where Pd is the diastolic BP measurement, while td is the time
instant corresponding to the occurrence of diastolic BP relative to
the beginning of systole, computed as the time interval between
the ECG R-wave and the corresponding diastolic BP. Note that
VðtdÞ ¼ Ved. This step may be interpreted as predicting the value
of Ved corresponding to Pd for a specified ES (this in turn implies
that the value of predicted Ved depends on the assumed value of
ES). In Step 3, Ves  V0 is predicted using Eq. (3a) based on the
measurement of mean BP (Fig. 2(d)) assuming that Pes ffi Pm.
Finally, in Step 4, the LV P–V loop is constructed and SV is pre-
dicted as SV ¼ Ved  Ves (Fig. 2(a)). In this way, scaled BVs
(including EDV, ESV and SV) can be predicted solely based on
an arterial BP waveform and the ECG measurements, where the
scaling depends on the value of ES assumed.
It is noted that the adverse impact of the assumed ES on the
fidelity of predicted volumes may be minimal. As can be seen in
Fig. 2(a), changes in ES are accompanied by the corresponding
changes in Ved and Ves: as ES becomes larger, Ved and Ves become
smaller (which can also be verified from Eqs. (3a) and (4)). To illus-
trate, consider the triangle constructed by the ðVðtÞ; PðtÞÞ coordi-
nates ðV0; 0Þ, ðVes; PesÞ, and ðVed; 0Þ. An increase in ES leads to a
linearly proportional decrease in Ved and Ves (here the decrease in
Ved is not strictly linear, since it is subject to both end-systolic and
end-diastolic P–V relationships as shown in Eq. (4); yet, the contribu-
tion of end-diastolic P–V relationship is typically small at diastolic
BP). Thus, ES primarily affects the scaling associated with the pre-
dicted volumes, but the volumes thus predicted still exhibit (approxi-
mately) linear correlation with the actual volumes.
Feedback Control. It is well known that the fluid augmented
to the body is distributed in blood and interstitial fluid in both
hypovolemic and normovolemic states [57,58]. However, most of
the fluid augmented beyond a certain hypervolemic level is not
stored in blood but is shifted to interstitial fluid [59]. This leads to
a decrease in the sensitivity of BV to augmented fluid as BV
increases. Noting that EDV predicted by the RBV estimator is a
scaled value, a closed-loop controller may be designed so that the
relative change in EDV is regulated at a reference target in a run-
to-run fashion. In this approach, each resuscitation run starts when
BV response to fluid bolus from the prior run has reached a steady
state. In each resuscitation run, our closed-loop controller per-
forms three tasks: (1) it predicts RBV; (2) it refines the predicted
RBV via a smoothing technique; and (3) it computes and then
applies fluid bolus required to drive the RBV to its target value.
As described in the “Model-Based BV Estimation” section, the
RBV estimator predicts the EDV response (denoted as EDVðkÞ)
to the fluid VFðkÞ at the end of kth resuscitation run by analyzing
an arterial BP and the ECG. Then, the RBV dVðkÞ, defined as the
relative change in EDV, at the kth resuscitation run is computed
as follows:
dV kð Þ ¼ EDV k
ð Þ  EDV k  1ð Þ




where EDVðk  1Þ is the EDV response associated with the
(k 1)-th resuscitation run, and V is a normalizing volume to
reflect the fact that RBV also depends on VFðkÞ: dVðkÞ is propor-
tional to VFðkÞ. dVðkÞ is compared with the reference dVrðkÞ, and
the fluid to be augmented during the (kþ 1)-th run VFðk þ 1Þ is
determined by the closed-loop controller based on the error
between dVrðkÞ and dVðkÞ.
In this paper, the target is defined as 15% change in EDV in
response to 500 ml fluid augmentation in the steady-state (dVrðkÞ
¼ 0.15 and V ¼ 500 ml; note that a target of 15% used here is
commensurate with the targets used in the previous investigations
[60–64]). In our initial effort to demonstrate the feasibility of the
proposed approach, we employed a classical proportional–
integral–derivative (PID) controller as the closed-loop controller.
In each resuscitation run, the PID controller compares dVðkÞ with
dVrðkÞ to determine the fluid to be augmented. The control com-
mand is computed by
u kð Þ ¼ Kpe kð Þ þ Ki
X
e kð Þ þ Kd




where k is the sequence of fluid administration,
eðkÞ¢rðkÞ  yðkÞ ¼ dV rðkÞ  dVðkÞ, Kp, Ki and Kd are the PID
gains, respectively, and Ts is the sampling interval.
Noting that LV elastance decreases as BV increases [65–67],
the closed-loop fluid resuscitation system may benefit from appro-
priate updating of the value of ES in the RBV estimator, so that
RBV can be predicted more accurately. An increase in BV may
result in a decrease in HR via autonomic-cardiac regulation,
thereby increasing the ejection duration [68–70]. Since quantita-
tive relationship between the decrease in ES and the associated
increase in ejection duration during fluid resuscitation does not
seem to be established, we incorporated a simple updating rule for
ES shown in Eq. (7) into the closed-loop fluid resuscitation system
ES kð Þ ¼
Tes 0ð Þ
Tes kð Þ
ES 0ð Þ (7)
where ESðkÞ is the value of LV elastance assumed by the RBV
estimator in the kth run, and TesðkÞ is the associated ejection
duration.
Our preliminary in silico simulation showed that the sequence
of dV predicted by the model-based RBV estimator (dVðkÞ, k¼ 1,
  ,N) was often subject to inaccuracy due to errors associated
with the estimation of EDV (EDVðkÞ, k¼ 0,   ,N; presumably
caused by the simplifying assumptions for the RBV estimator,
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including the use of population-averaged A and B, mean BP as
surrogate of end-systolic BP, and the errors associated with Eq.
(7)), which often led to premature under-resuscitation or over-
resuscitation (see Fig. 3 for an example of under-resuscitation).
To improve the robustness of the controller to the inaccuracy in
dVðkÞ, a model-based smoothing is employed. Our in silico simu-
lation results suggest that the sequence of dVðkÞ may be







where dV ðkÞ is the smoothed dVðkÞ, and a1ðkÞ, a2ðkÞ and a3ðkÞ
are the parameters to be tuned. The smoothing model in Eq. (8) is
updated at every resuscitation run. More specifically, once dVðkÞ
is computed using Eq. (5) at the end of kth run, the parameters
a1ðkÞ, a2ðkÞ and a3ðkÞ in the smoothing model are updated by fit-
ting the model in Eq. (8) to the sequence dVðjÞ, j ¼ 1;…; k
fa1ðkÞ; a2ðkÞ; a3ðkÞg ¼ argmin
Xk
j¼1















Then, the closed-loop controller computes the error eðkÞ as fol-
lows so that the volume is optimized in an aggressive fashion (in
that eðkÞ becomes maximally negative to result in maximal con-
trol action in this way)
eðkÞ ¼ dV rðkÞ max dVðkÞ; dVðkÞ
n o
(10)
The fluid resuscitation is completed when both dV ðkÞ and dVðkÞ
fall below dV rðkÞ, that is, uðkÞ ¼ 0 if eðkÞ  0. Hence, assuming
that the model-based RBV estimator provides reasonably accurate
prediction of RBV, the closed-loop system is stable as far as BV is
concerned because BV cannot grow indefinitely under the proposed
control law. On the other hand, steady-state error in BV may persist
because fluid inappropriately infused due to the inaccuracy associ-
ated with the prediction of RBV cannot be withdrawn.
Methods
The validity of the closed-loop fluid resuscitation system pro-
posed in this paper was tested via a rigorous in silico simulation
study. A high-fidelity cardiovascular physiology model reported
in a previous study [71–73] was implemented and refined to be
applicable to the in silico simulation. Then, this model was used
to produce a total of 100 hypovolemia cases with wide-ranging
physiologic conditions. The closed-loop fluid resuscitation system
was simulated on the 100 hypovolemic cases to evaluate the
model-based RBV estimator and run-to-run closed-loop fluid
resuscitation controller. Details follow.
In Silico Model. A mathematical model was employed that
incorporates the heart, systemic and pulmonary circulations (both
arterial and venous) and the autonomic-cardiac regulation mecha-
nisms for TPR, systemic venous unstressed volumes, HR and ES
[71–73]. Each of the left and right hearts was modeled as a vari-
able elastance model [71]. The systemic and pulmonary circulations
were modeled as lumped 5- and 3-compartment systems, respec-
tively. Each compartment employed lumped flow resistance, com-
pliance, and unstressed volume. The autonomic-cardiac regulation
model included afferent and efferent pathways as well as the
actions of effector mechanisms. In sum, the in silico model was
described by a set of 22 nonlinear ordinary differential equations.
The change in BV due to hypovolemia and fluid resuscitation
was simulated by altering the systemic arterial BV. It was
assumed that fluid augmented to the patient is distributed to the
blood and interstitial fluid at a constant ratio of 1:2.3 in the steady
state [59].
In Silico Closed-Loop Control Simulation. To evaluate the
proposed closed-loop fluid resuscitation system, a total of 100
hypovolemia cases was created by randomly perturbing the key
model parameters from the respective nominal value, including
the autonomic-cardiac regulation gains (up to 650%), flow resis-
tances (up to 650%), LV and RV elastances (up to 650%), HR
(up to 620%), venous unstressed volumes (up to 610%), and
end-diastolic P–V relationship parameters A and B (up to 620%).
These ranges were determined via trial and error so that the in sil-
ico model could produce reasonable key hemodynamic responses
of BP, HR, and CO both before and after fluid resuscitation (see
“Results and Discussion” section).
For each simulated hypovolemia case, the closed-loop fluid
resuscitation system first employed the RBV estimator to predict
scaled EDV, assuming nominal (population-averaged) ESð0Þ, A
and B parameters: ESð0Þ ¼ 3 mm Hg, A ¼ 0:014 ml1, and B
¼ 1:5 mmHg. It then augmented 500 ml fluid (¼ VFð1Þ) and
assessed the RBV response, as the relative change in scaled EDV,
via the RBV estimator (dVð1Þ). In case the RBV was greater than
15% per 500 ml fluid, the closed-loop fluid resuscitation system
computed the fluid to be augmented in the next run using Eq. (6).
The fluid thus computed was augmented, and the RBV response was
again assessed via the RBV estimator. This iterative control action
was repeated until the RBV response to fluid resuscitation dropped
to below 15% per 500 ml fluid. The PID controller gains were tuned
by rigorous trial and error to yield a fluid volume ranging from
400 ml to 1 l in all the hypovolemia cases, so that the administration
of extremely large/small volume of fluid could be prevented.
To further investigate the efficacy of the proposed closed-loop
fluid resuscitation system, the closed-loop controller in Eq. (6)
was run with PP as controlled variable instead of RBV.
Fig. 3 Model-based smoothing of RBV. The RBV predicted by
the model-based RBV estimator at the end of fifth fluid resusci-
tation run (dV ð5Þ 5 14.8% < 15% target) was not accurate,
resulting in premature fluid resuscitation that was stopped after
fifth run. The model-based smoothing predicted dV ð5Þ
5 16.1% > 15% and the fluid resuscitation continued up to
eighth run, preventing premature fluid resuscitation.
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Data Analysis. For each simulated hypovolemia case, the pre-
dicted EDV and RBV values as well as other physiologic
responses (such as BP) were archived across the run-to-run
closed-loop fluid resuscitation. Then, the proposed closed-loop
fluid resuscitation system was evaluated by analyzing the follow-
ing aspects. First, the model-based RBV estimator was evaluated
based on the predicted BV measures (Ved, Ves and SV in
Fig. 2(a)). Noting that these measures are relative, they were cali-
brated to their true counterparts. Then, the goodness of the meas-
ures was quantified by their correlations to the respective true
counterparts. Second, the closed-loop controller was evaluated
based on its volume optimization performance. The desired
amount of fluid augmentation was computed as the total volume
of fluid augmented by the time the measured RBV attained 15%
per 500 ml fluid challenge. The actual volume of fluid augmented
was computed as the total volume of fluid augmented by the
closed-loop controller in Eq. (6) based on the predicted RBV as
feedback. Then, the actual fluid volume was compared with its
desired counterpart.
The RBV-based versus PP-based closed-loop fluid resuscitation
systems were compared via the accuracy in predicting BV as well
as the errors associated with the volume optimization.
Results and Discussion
Closed-loop automated fluid resuscitation may make contribu-
tions in improving the efficacy of hypovolemia treatment as well
as in reducing clinician’s workload. Many existing treatment pro-
tocols rely on nonlinear surrogates of BV, often leading to limited
volume optimization performance. In this paper, we proposed a
closed-loop fluid resuscitation system based on RBV, a linear sur-
rogate of BV. Reported in this paper are the initial design and in
silico testing of the proposed closed-loop fluid resuscitation
system.
In Silico Simulation. Figure 4 shows the distributions of the
initial and target BV, CO, HR, and BP spanned by the 100 in sil-
ico hypovolemia cases. Despite the constant initial BV of 4 l, ini-
tial CO (2.9 6 0.7 lpm), HR (129 6 19 bpm), and BP
(64 6 17 mmHg) as well as target BV (5.6 6 0.25 l), CO
(5.7 6 1.0 lpm), HR (84 6 11 bpm), and BP (99 6 9.1 mmHg) are
widely distributed, suggesting that the randomly produced in sil-
ico hypovolemia cases encompass wide-ranging hypovolemic
conditions, enabling a rigorous in silico testing of the closed-loop
fluid resuscitation system.
Fig. 4 Distributions of the initial and target BV, CO, and BP
Fig. 5 True versus predicted EDV and SV: (a) Model-based RBV estimator and (b) PP
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Model-Based BV Estimation. Figure 5 shows the correlation
between true versus predicted EDV values across the closed-loop
fluid resuscitation in all the subjects (Fig. 5(a)) and the correlation
between true EDV versus PP calibrated to EDV (Fig. 5(b)). The
model-based RBV estimator could yield scaled EDV and SV that
correlated well with the true EDV and SV after calibration to
account for the unknown ES (see Fig. 2(b)). In contrast, PP largely
underestimated both EDV and SV due to the nonlinear LV P-V
relationship: in particular, the slope of the diastolic P–V relation-
ship gets steeper as EDV increases whereas its systolic counter-
part gets more gradual with EDV (Fig. 2), which essentially
reduces the change in PP relative to EDV.
The efficacy of the model-based RBV estimator may also be
demonstrated by its ability to predict the LV ejection fraction
(EF), an important inotropic measure of the heart [74]. Figure 6
shows that the EF predicted by the model-based RBV estimator
correlates well with the true EF even without calibration. As men-
tioned earlier, the RBV estimator can only estimate scaled (rather
than absolute) BV measures since it utilizes only BP but not BV
or blood flow (which is why ES must be assumed in Fig. 2(a)).
Regardless, noting that EF is the ratio between SV and EDV
(EF¼SV/EDV), the RBV estimator was able to predict the abso-
lute value of the EF by canceling the unknown scaling factor
imposed on EDV and SV due to ES. This result suggests that the
model-based RBV estimator preserves the absolute scaling rela-
tionship between EDV and SV it predicts, making them credible
and consistent surrogates of the BV status.
Feedback Control. Figure 7(a) shows the results of closed-
loop control across the 100 hypovolemia cases. The closed-loop
controller, when used with the RBV estimator, could offer a tight
regulation of BV at the desired relative change of 15% per 500 ml
fluid challenge. On the contrary, the same controller, when used
with PP, performed poorly by drastically under-resuscitating all
the cases. As illustrated in Fig. 5(b), this is due to the underesti-
mation of EDV by PP. In fact, the RBV at the last fluid resuscita-
tion run with PP ranged between 22% and 34%, which is largely
higher than the desired value of 15%. This contrasting target regu-
lation capability associated with the RBV estimator versus PP
entailed a large difference in their volume optimization efficacy:
the BV regulation error at the end of the fluid resuscitation was
7.98 6 172 ml and 779 6 147 ml for the RBV estimator and
PP, respectively, which amounted to 0.18 6 3.04% and
13.9 6 2.65% of the desired BV (Fig. 7(b)). Across the 100
cases, the desired change in BV was 1616 6 249 ml. In the case of
the RBV estimator, the actual change in BV after the completion
of fluid resuscitation was above the target in 50 cases, with the
over-resuscitated BV of only 146 6 87 ml. The actual change in
BV was below the target in the remaining 50 cases, with the
under-resuscitated BV of only 130 6 113 ml. In the case of PP,
the actual change in BV was below the target in all 100 hypovole-
mia cases, with the large under-resuscitated volume of
779 6 147 ml. In sum, the in silico testing results strongly sug-
gested the potential advantage of exploiting linear surrogates of
BV in optimizing BV via closed-loop fluid resuscitation.
Limitations. The study conducted in this paper has a few limi-
tations. First, the RBV estimator has several weaknesses. It
involved population-averaged parameters A and B in the end-
diastolic P–V relationship in Eq. (1b) that may incur inaccuracy in
predicting EDV and RBV. In addition, the activation function
/ðtÞ was assumed to be perfectly known. It has been suggested
from previous work on LV P–V loop models [47,50,75] that this
may be the case. However, any errors associated with /ðtÞ may
compromise the fidelity of EDV and RBV predicted by the RBV
estimator. Further, it was also assumed that ES may be tracked
accurately from the ejection duration (see Eq. (7)), which is essen-
tially an approximation that must be validated experimentally.
Follow-up work to investigate these weaknesses of the RBV esti-
mator is required to rigorously justify these simplifications (and
improve if necessary), ideally based on experimental study. Sec-
ond, the tuning of the controller gains in this paper was empiric.
The focus of this paper was to investigate a new approach to
closed-loop fluid resuscitation guided by a linear surrogate of BV.
Thus, primary effort was made toward initial design and in silico
testing of the proposed closed-loop fluid resuscitation system
rather than optimizing each element in the system. In the follow-
Fig. 6 True versus predicted EF
Fig. 7 Efficacy of run-to-run closed-loop fluid resuscitation based on predicted RBV versus
PP. (a) The relative (percent) change in true EDV at the first and the last runs. The control
objective was to regulate the change in the last run at 15% (green horizontal line). (b) Percent
BV regulation error.
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up study, more systematic model-based control design and analy-
sis must be conducted to optimize the performance of the closed-
loop controller. Third, some crucial physiological elements were
not considered in the in silico model used in this paper for control-
ler testing. In particular, the in silico model used in this paper did
not include models to reproduce urine excretion. More rigorous in
silico testing of the proposed closed-loop fluid resuscitation sys-
tem is desired. Fourth, potential real-world challenges in imple-
menting the proposed closed-loop fluid resuscitation system were
not examined. These challenges include, among others, the
robustness of the system to sensor noise, beat-to-beat variability
in BP and ECG, and time-varying fluid distribution between blood
and interstitial fluid. The closed-loop fluid resuscitation system
must ultimately be validated in experimental investigations.
Conclusion and Future Work
In this paper, we presented and conducted an in silico evalua-
tion of a closed-loop control system for fluid resuscitation guided
by a linear surrogate of BV. Rigorous in silico study showed that
the proposed closed-loop fluid resuscitation system is effective in
optimizing volume to overcome hypovolemia by virtue of its abil-
ity to predict and exploit a linear surrogate of BV via the model-
based RBV estimator. Future effort will be directed to further
improvement and more rigorous model-based and experimental
investigation of the proposed closed-loop fluid resuscitation
system.
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